相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Ampicillin exacerbates acetaminophen-induced acute liver injury by inducing intestinal microbiota imbalance and butyrate reduction
Zhan-Ming Li et al.
LIVER INTERNATIONAL (2023)
ALDH2 deficiency increases susceptibility to binge alcohol-induced gut leakiness, endotoxemia, and acute liver injury in mice through the gut-liver axis
Wiramon Rungratanawanich et al.
REDOX BIOLOGY (2023)
Lacticaseibacillus paracasei sh2020 induced antitumor immunity and synergized with anti-programmed cell death 1 to reduce tumor burden in mice
Shi-Long Zhang et al.
GUT MICROBES (2022)
Microbiota in health and diseases
Kaijian Hou et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)
Therapeutic pipeline in nonalcoholic steatohepatitis
Raj Vuppalanchi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)
Lactobacillus bile salt hydrolase substrate specificity governs bacterial fitness and host colonization
Matthew H. Foley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Distinct signatures of gut microbiome and metabolites associated with significant fibrosis in non-obese NAFLD
Giljae Lee et al.
NATURE COMMUNICATIONS (2020)
Diet Consisting of Balanced Yogurt, Fruit, and Vegetables Modifies the Gut Microbiota and Protects Mice against Nonalcoholic Fatty Liver Disease
Chao-Yue Kong et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2019)
ALDH2 Repression Promotes Lung Tumor Progression via Accumulated Acetaldehyde and DNA Damage
Kaimi Li et al.
NEOPLASIA (2019)
Vinyl chloride-induced interaction of nonalcoholic and toxicant-associated steatohepatitis: Protection by the ALDH2 activator Alda-1
Liya Chen et al.
REDOX BIOLOGY (2019)
Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development
Juliette Mouries et al.
JOURNAL OF HEPATOLOGY (2019)
The Role of Gut Microbiota in Intestinal Inflammation with Respect to Diet and Extrinsic Stressors
Stefani Lobionda et al.
MICROORGANISMS (2019)
Intestinal Microbiota Protects against MCD Diet-Induced Steatohepatitis
Kai Markus Schneider et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Intestine farnesoid X receptor agonist and the gut microbiota activate G-protein bile acid receptor-1 signaling to improve metabolism
Preeti Pathak et al.
HEPATOLOGY (2018)
A Multi-strain Probiotic Reduces the Fatty Liver Index, Cytokines and Aminotransferase levels in NAFLD Patients: Evidence from a Randomized Clinical Trial
Nazarii Kobyliak et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
Mechanisms of NAFLD development and therapeutic strategies
Scott L. Friedman et al.
NATURE MEDICINE (2018)
Triggering and resolution of inflammation in NASH
Susanne Schuster et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Butyrate Protects Mice Against Methionine-Choline-Deficient Diet-Induced Non-alcoholic Steatohepatitis by Improving Gut Barrier Function, Attenuating Inflammation and Reducing Endotoxin Levels
Jianzhong Ye et al.
FRONTIERS IN MICROBIOLOGY (2018)
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Anna M. Diehl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
VHL deficiency augments anthracycline sensitivity of clear cell renal cell carcinomas by down-regulating ALDH2
Yao-Hui Gao et al.
NATURE COMMUNICATIONS (2017)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The Natural Course of Non-Alcoholic Fatty Liver Disease
Luis Calzadilla Bertot et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
The longitudinal effect of the aldehyde dehydrogenase 2*2 allele on the risk for nonalcoholic fatty liver disease
K. Oniki et al.
NUTRITION & DIABETES (2016)
ALDH2 Deficiency Promotes Ethanol-Induced Gut Barrier Dysfunction and Fatty Liver in Mice
Kamaljit K. Chaudhry et al.
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)
Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease
Venkatanarayana Gangarapu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagy
Rui Guo et al.
JOURNAL OF HEPATOLOGY (2015)
Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction
Changtao Jiang et al.
NATURE COMMUNICATIONS (2015)
Transmission of Atherosclerosis Susceptibility with Gut Microbial Transplantation
Jill C. Gregory et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Hepatic Injury in Nonalcoholic Steatohepatitis Contributes to Altered Intestinal Permeability
Jay Luther et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2015)
Aldehyde Dehydrogenase 2 Deficiency Ameliorates Alcoholic Fatty Liver but Worsens Liver Inflammation and Fibrosis in Mice
Hyo-Jung Kwon et al.
HEPATOLOGY (2014)
Mitochondrial Aldehyde Dehydrogenase Activation by Alda-1 Inhibits Atherosclerosis and Attenuates Hepatic Steatosis in Apolipoprotein E-Knockout Mice
Aneta Stachowicz et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Lactobacillus casei strain Shirota protects against nonalcoholic steatohepatitis development in a rodent model
Hirofumi Okubo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Tiphaine Le Roy et al.
GUT (2013)
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
Raluca Pais et al.
JOURNAL OF HEPATOLOGY (2013)
Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease
Luke Boulter et al.
NATURE MEDICINE (2012)
The role of oxidative stress in non-alcoholic steatohepatitis
G. H. Koek et al.
CLINICA CHIMICA ACTA (2011)
Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde
Heng Ma et al.
EUROPEAN HEART JOURNAL (2011)
Enterococcus faecalis Metalloprotease Compromises Epithelial Barrier and Contributes to Intestinal Inflammation
Natalie Steck et al.
GASTROENTEROLOGY (2011)
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
Zeneng Wang et al.
NATURE (2011)
Evolution of Inflammation in Nonalcoholic Fatty Liver Disease: The Multiple Parallel Hits Hypothesis
Herbert Tilg et al.
HEPATOLOGY (2010)
Refined Geographic Distribution of the Oriental ALDH2*504Lys (nee 487Lys) Variant
Hui Li et al.
ANNALS OF HUMAN GENETICS (2009)
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Dunyaporn Trachootham et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Bile Acids Metabonomic Study on the CCl4- and (alpha-Naphthylisothiocyanate-Induced Animal Models: Quantitative Analysis of 22 Bile Acids by Ultraperformance Liquid Chromatography-Mass Spectrometry
Li Yang et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2008)
Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet
Mary E. Rinella et al.
JOURNAL OF LIPID RESEARCH (2008)
Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart
Che-Hong Chen et al.
SCIENCE (2008)
Design and validation of a histological scoring system for nonalcoholic fatty liver disease
DE Kleiner et al.
HEPATOLOGY (2005)
Bile salt deconjugation ability, bile salt hydrolase activity and cholesterol co-precipitation ability of lactobacilli strains
MT Liong et al.
INTERNATIONAL DAIRY JOURNAL (2005)
Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance
HY Xu et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
分享论文
